| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0B | $16.4B | $16.1B | $20.9B | $8.3B | $2.5B | $9.4B | — |
| Cost of Revenue | $10.5B | $10.7B | $10.7B | $16.9B | $5.1B | $6.1B | $8.2B | — |
| Gross Profit | — | — | — | — | — | $0.8B | $0.6B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.3B | $2.7B | $2.6B | $1.7B | $-1.3B | $-0.0B | $-0.1B | $0.1B |
| Net Income | $1.9B | $1.3B | $1.3B | $1.2B | $-1.6B | $-0.2B | $0.0B | $0.1B |
| EPS (Basic) | $8.52 | $5.77 | $3.69 | $3.95 | $-7.26 | $-0.62 | $-0.60 | $1.17 |
| EPS (Diluted) | $8.49 | $5.74 | $3.66 | $3.88 | $-7.26 | $-0.62 | $-0.60 | $1.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.2B | $22.7B | $20.7B | $19.6B | $15.9B | $18.8B | $16.9B | $14.4B |
| Current Assets | $2.4B | $2.3B | $2.2B | $2.4B | $1.5B | $1.7B | $1.4B | $1.3B |
| Cash & Equivalents | $0.2B | $0.2B | $0.1B | $0.2B | $0.2B | $0.3B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.5B | $3.2B | $2.8B | $3.1B | $1.8B | $1.9B | $2.8B | $1.6B |
| Stockholders' Equity | $3.1B | $2.6B | $2.7B | $2.7B | $2.7B | $4.9B | $6.1B | $6.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.9B | $3.6B | $3.2B | $2.4B | $1.7B | $1.4B | $1.1B | — |
| Investing Cash Flow | $-3.6B | $-3.0B | $-2.4B | $-4.1B | $-0.7B | $-3.1B | $-3.1B | — |
| Capital Expenditures | $3.3B | $3.0B | $2.4B | $1.3B | $1.0B | $2.9B | $3.1B | $1.3B |
| Financing Cash Flow | $-0.3B | $-0.6B | $-0.9B | $1.8B | $-1.1B | $1.8B | $2.1B | — |